---
title: Mammography SPECT With Rotating Slant Hole Collimator
nct_id: NCT00328354
overall_status: WITHDRAWN
sponsor: Johns Hopkins University
study_type: OBSERVATIONAL
primary_condition: Breast Cancer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00328354.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00328354"
ct_last_update_post_date: 2018-04-06
last_seen_at: "2026-05-12T06:21:19.013Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Mammography SPECT With Rotating Slant Hole Collimator

**NCT ID:** [NCT00328354](https://clinicaltrials.gov/study/NCT00328354)

## Key Facts

- **Status:** WITHDRAWN
- **Why Stopped:** Ran out of time/ funding
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 0
- **Lead Sponsor:** Johns Hopkins University
- **Conditions:** Breast Cancer
- **Start Date:** 2006-12
- **Completion Date:** 2007-12
- **CT.gov Last Update:** 2018-04-06

## Brief Summary

The goal is to conduct a pilot study to determine the feasibility of the clinical use of RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical protocol.

## Detailed Description

The goal of this protocol is to develop and evaluate a novel SPECT imaging technique for imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The motivation is the requirement of a low cost RMSSH collimator and a conventional Large-Field-Of-View (LFOV) camera. It is believed that RMSSH SPECT is particularly suitable for applications in breast imaging.

## Eligibility

- **Minimum age:** 35 Years
- **Maximum age:** 80 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed with breast cancer.

Exclusion Criteria:

* Pregnant (or possibly pregnant)
* Lactating
* Unable to give consent
* Weights over 300 pounds
* Women who have already undergone definitive surgical treatment to their breast for breast cancer will not be eligible.
```

## Locations (1)

- Johns Hopkins Outpatient Center, Baltimore, Maryland, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.johns hopkins outpatient center|baltimore|maryland|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00328354.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00328354*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*